Cogent Biosciences, Inc. (COGT)
39.76
-0.48
(-1.19%)
USD |
NASDAQ |
Jul 24, 16:00
39.74
-0.02
(-0.05%)
After-Hours: 20:00
Cogent Biosciences Market Cap : 6.792B for July 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| July 24, 2026 | 6.792B |
| July 23, 2026 | 6.874B |
| July 22, 2026 | 6.754B |
| July 21, 2026 | 6.771B |
| July 20, 2026 | 6.542B |
| July 17, 2026 | 6.676B |
| July 16, 2026 | 6.481B |
| July 15, 2026 | 6.713B |
| July 14, 2026 | 6.578B |
| July 13, 2026 | 6.399B |
| July 10, 2026 | 6.640B |
| July 09, 2026 | 6.920B |
| July 08, 2026 | 6.828B |
| July 07, 2026 | 6.834B |
| July 06, 2026 | 6.737B |
| July 02, 2026 | 6.609B |
| July 01, 2026 | 6.573B |
| June 30, 2026 | 6.611B |
| June 29, 2026 | 6.617B |
| June 26, 2026 | 6.508B |
| June 25, 2026 | 6.493B |
| June 24, 2026 | 6.411B |
| June 23, 2026 | 6.202B |
| June 22, 2026 | 6.122B |
| June 18, 2026 | 5.900B |
| Date | Value |
|---|---|
| June 17, 2026 | 5.751B |
| June 16, 2026 | 5.649B |
| June 15, 2026 | 5.666B |
| June 12, 2026 | 5.654B |
| June 11, 2026 | 5.572B |
| June 10, 2026 | 5.360B |
| June 09, 2026 | 5.463B |
| June 08, 2026 | 5.323B |
| June 05, 2026 | 5.299B |
| June 04, 2026 | 5.601B |
| June 03, 2026 | 5.511B |
| June 02, 2026 | 5.596B |
| June 01, 2026 | 5.946B |
| May 29, 2026 | 5.972B |
| May 28, 2026 | 6.044B |
| May 27, 2026 | 5.897B |
| May 26, 2026 | 5.799B |
| May 22, 2026 | 5.582B |
| May 21, 2026 | 5.567B |
| May 20, 2026 | 5.626B |
| May 19, 2026 | 5.340B |
| May 18, 2026 | 5.358B |
| May 15, 2026 | 5.584B |
| May 14, 2026 | 5.842B |
| May 13, 2026 | 5.859B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vir Biotechnology, Inc. | 1.401B |
| Revolution Medicines, Inc. | 37.88B |
| ImmunityBio, Inc. | 7.436B |
| Erasca, Inc. | 5.940B |
| Tyra Biosciences, Inc. | 1.822B |
Market Cap Related Metrics
| PEG Ratio | -3.464 |
| Price to Book Value | 12.51 |
| Price | 39.76 |
| Earnings Yield | -6.35% |
| PEGY Ratio | -3.464 |